Earnings per Share (Tables)

6 Months Ended

Jun. 30, 2022

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of the basic and diluted earnings per share attributable to the Company's common shareholders for the three and six months ended June 30, 2022 and 2021:


	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands, except per share amounts)	2022		2021		2022		2021
EPS numerator:
Net income (loss)	$	866	$	732	$	(650)	$	(1,550)

EPS denominator:
Weighted average shares outstanding – basic	10,423		10,252		10,422		9,738
Impact of dilutive securities(1)	144		217		—		—
Weighted average shares outstanding – diluted	10,567		10,469		10,422		9,738

EPS:
Basic	$	0.08	$	0.07	$	(0.06)	$	(0.16)
Diluted	$	0.08	$	0.07	$	(0.06)	$	(0.16)

(1) For the six months ended June 30, 2022 and 2021, the Company excluded 150,420 and 225,974, respectively, of potentially dilutive securities related to certain of the Company's outstanding common stock warrants, shares issued in conjunction with the Company's ESPP and nonvested RSUs. These securities were excluded from the computation as their effect would have been anti-dilutive. As a result, the computations of net loss per share for the six months ended June 30, 2022 and 2021 is the same for both basic and diluted.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the securities that were antidilutive or out-of-the-money, and therefore, were not included in the computations of diluted income per common share:


	Three Months Ended June 30,		Six Months Ended June 30,
	2022	2021	2022	2021
In-the-money warrants	—	—	—	—
Out-of-the-money warrants (see Note 7)	1,229,643	4,403,930	1,229,643	4,403,930
Service-based RSUs (See Note 14)	17,595	334	72,871	142,120
Performance and market-based RSUs(1)	48,229	13,929	85,969	79,971
Employee Stock Purchase Plan	—	—	8,451	4,778
Total	1,295,467	4,418,193	1,396,934	4,630,799

(1) For the three and six months ended June 30, 2022 and 2021, certain MRSU awards (each defined in Note 14) were not included in the computation of diluted income per common share because the performance and market conditions were not satisfied during the periods and would not be satisfied if the reporting date was at the end of the contingency period.